The prodromal phase of obesity-related chronic kidney disease: Early alterations in cardiovascular and renal function in obese children and adolescents

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.4, 2013, Pages

  Doyon, Anke ^a   Schaefer, Franz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular; Child; Chronic kidney disease; Obesity; Overweight

Indexed keywords

ANTILIPEMIC AGENT; ANTIOBESITY AGENT;

AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHILDHOOD OBESITY; CHRONIC KIDNEY DISEASE; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; FOCAL GLOMERULOSCLEROSIS; GENETIC SUSCEPTIBILITY; HUMAN; KIDNEY INJURY; LIFESTYLE MODIFICATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PULSE WAVE; REVIEW; RISK FACTOR; SODIUM RESTRICTION; TREATMENT INDICATION; WEIGHT REDUCTION;

CARDIOVASCULAR; CHILD; CHRONIC KIDNEY DISEASE; OBESITY; OVERWEIGHT;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; HUMANS; KIDNEY; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84890102979     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft263     Document Type: Review

References (97)

1. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006; 1: 11-25
2. Ogden CL, Flegal KM, Carroll MD et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-1732
3. Ogden CL, Carroll MD, Kit BK et al. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307: 483-490
4. de Onis M, Blössner M, Borghi E. Global prevalence and trendsof overweight and obesity among preschool children. Am J Clin Nutr 2010; 92: 1257-1264
5. World Health Organ Tech Rep Ser. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO, 2000; 894: 1-12, 1-253
6. Lobstein T, Baur L, Uauy R. IASO International Obesity Task-Force. Obesity in children and young people: a crisis in public health. Obes Rev 2004; 5(Suppl. 1): 4-104
7. Ogden CL, Kuczmarski RJ, Flegal KM et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60
8. Cole TJ, Bellizzi MC, Flegal KM et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243
9. Greenberg JA. Obesity and early mortality in the US. Obesity 2012; 21: 405-412
10. de Onis M, Lobstein T. Defining obesity risk status in the general childhood population: which cut-offs should we use? Int J Pediatr Obes 2010; 5: 458-460
11. de Onis M. Development of a WHO growth reference for schoolaged children and adolescents. Bull World Health Organ 2007; 85: 660-667
12. WHO Multicentre Growth Reference Study Group. WHO child growth standards based on length/height, weight and age. Acta Paediatr Suppl 2006; 450: 76-85
13. van Stralen MM, Velde te SJ, van Nassau F et al. Weight status of European preschool children and associations with family demographics and energy balance- related behaviours: a pooled analysis of six European studies. Obes Rev 2012; 13: 29-41
14. Cattaneo A, Monasta L, Stamatakis E et al. Overweight and obesity in infants and pre-school children in the European Union: a review of existing data. Obes Rev 2010; 11: 389-398
15. Wijnhoven TMA, van Raaij JMA, Spinelli A et al. WHO European Childhood Obesity Surveillance Initiative 2008: weight, height and body mass index in 6-9-year-old children. Pediatr Obes 2012; 8: 79-97
16. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obes Rev 2003; 4: 195-200
17. Moss M. The extraordinary science of addictive junk food. New York Times. 2013
18. Maes HH, Neale MC, Eaves LJ. Genetic and environmentalfactors in relative body weight and human adiposity. Behav Genet 1997; 27: 325-351
19. Manco MM, Dallapiccola BB. Genetics of pediatric obesity. Pediatrics2012; 130: 123-133
20. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976; 295: 349-353
21. Heijmans BT, Tobi EW, Stein AD et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008; 105: 17046- 17049
22. Bygren LO. Intergenerational health responses to adverse and enriched environments. Annu Rev Public Health 2013; 34: 49-60
23. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev 2006;82: 485-491
24. Freedman DS, Khan LK, Serdula MK et al. The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics 2005; 115: 22-27
25. The NS, Suchindran C, North KE et al. Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 2010; 304: 2042-2047
26. Serdula MK, Ivery D, Coates RJ et al. Do obese children become obese adults? A review of the literature. Prev Med 1993; 22: 167-177
27. Berenson GS, Srinivasan SR, Bao W et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-1656
28. Freedman DS, Patel DA, Srinivasan SR et al. The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2008; 32: 749-756
29. Must A, Jacques PF, Dallal GE et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350-1355
30. Reilly JJ, Kelly J. Long-term impact of overweight and obesity inchildhood and dolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes Relat Metab Disord 2011; 35: 891-898
31. Lobstein T, Jackson-Leach R. Estimated burden of paediatric obesity and co- morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes 2006; 1: 33-41
32. Henry SL, Barzel B, Wood-Bradley RJ et al. Developmental origins of obesity-related hypertension. Clin Exp Pharmacol Physiol 2012; 39: 799-806
33. Landsberg L, Aronne LJ, Beilin LJ et al. Obesity-related hypertension:pathogenesis, ardiovascular risk, and treatment. J Clin Hypertens2012; 15: 14-33
34. Clarke WR,Woolson RF, Lauer RM. Changes in ponderosity andblood pressure in childhood: the Muscatine Study. Am J Epidemiol 1986; 124: 195-206
35. Wühl E, Witte K, Soergel M et al. German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20: 1995-2007
36. Simonetti GD, Schwertz R, Klett M et al. Determinants of blood pressure in preschool children: the role of parental smoking. Circulation 2011; 123: 292-298
37. Rosner B, Cook N, Portman R et al. Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 2008; 167: 653-666
38. Falkner B, Gidding SS, Ramirez-Garnica G et al. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr 2006; 148: 195-200
39. Litwin M, Sladowska J, Antoniewicz J et al. Metabolic abnormalities, insulin resistance, and metabolic syndrome in children with primary hypertension. Am J Hypertens 2007; 20: 875-882
40. Litwin M, Trelewicz J, Wawer Z et al. Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 2004; 19: 767-774
41. Davis PH, Dawson JD, Riley WA et al. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001; 104: 2815-2819
42. Raitakari OT, Juonala M, Kähönen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003; 290: 2277-2283
43. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction Of Cardiovascular Events And All-Cause Mortality With Arterial Stiffness. J Am Coll Cardiol 2010; 55: 1318-1327
44. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end- stage renal disease. Circulation 1999; 99: 2434-2439
45. Lurbe E, Torro I, Garcia-Vicent C et al. Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension 2012; 60: 550-555
46. Sakuragi S, Abhayaratna K, Gravenmaker KJ et al. Influence ofadiposity and physical activity on arterial stiffness in healthy children: the lifestyle of our kids study. Hypertension 2009; 53: 611-616
47. Niboshi A, Hamaoka K, Sakata K et al. Characteristics of brachial- ankle pulse wave velocity in Japanese children. Eur J Pediatr 2006; 165: 625-629
48. Charakida M, Jones A, Falaschetti E et al. Childhood obesity and vascular phenotypes. J Am Coll Cardiol 2012; 60: 2643-2650
49. Aggoun Y, Farpour-Lambert NJ, Marchand LM et al. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J 2008; 29: 792-799
50. Tounian P, Aggoun Y, Dubern B et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358: 1400-1404
51. Daniels SR, Loggie JMH, Khoury P et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97: 1907-1911
52. Litwin M, Niemirska A, Sladowska J et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 2006; 21: 811-819
53. Hanevold C, Waller J, Daniels S et al. International Pediatric Hypertension Association. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113: 328-333
54. Koopman LP, McCrindle BW, Slorach C et al. Interaction between myocardial and vascular changes in obese children: a pilot study. J Am Soc Echocardiogr 2012; 25: 401-410.e1
55. Barbosa JAA, Mota CCC, Simoes e Silva AC et al. Assessing preclinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging. Eur Heart J Cardiovasc Imaging 2013
56. Falaschetti E, Hingorani AD, Jones A et al. Adiposity and cardiovascular risk factors in a large contemporary population of prepubertal children. Eur Heart J 2010; 31: 3063-3072
57. Flechtner-Mors M, Thamm M, Wiegand S et al. Comorbidities related to BMI category in children and adolescents: German/ Austrian/Swiss obesity register APV compared to the German KiGGS study. Horm Res Paediatr 2012; 77: 19-26
58. Katzmarzyk PT, Srinivasan SR, Chen W et al. Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics 2004; 114: e198-e205
59. Litwin M, Sladowska J, Syczewska M et al. Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension. Pediatr Nephrol 2008; 23: 787-796
60. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919. - quiz 920
61. Pinhas-Hamiel O, Dolan LM, Daniels SR et al. Increased incidence of non-insulin- dependent diabetes mellitus among adolescents. J Pediatr 1996; 128(5 Pt 1): 608-615
62. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005; 146: 693-700
63. Reinehr T. Clinical presentation of type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord 2005; 29: S105-S110
64. Ejerblad E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702
65. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23: 381-389
66. Fox CS, Larson MG, Leip EP et al. Predictors of new-onsetkidney disease in a community-based population. JAMA 2004; 291: 844-850
67. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249(3 Pt 2): F324-F337
68. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509
69. Darouich S, Goucha R, Jaafoura MH et al. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis. Ultrastruct Pathol 2011; 35: 176-182
70. Abitbol CL, Chandar J, Rodríguez MM et al. Obesity and preterm birth: additive risks in the progression of kidney disease in children. Pediatr Nephrol 2009; 24: 1363-1370
71. Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol 2009; 5: 713-721
72. Goek O-N, Köttgen A, Hoogeveen RC et al. Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples. Nephrol Dial Transplant 2012; 27: 2839-2847
73. Soylemezoglu O, Duzova A, Yalcinkaya F et al. Chronic renal disease in children aged 5-18 years: a population-based survey in Turkey, the CREDIT-C study. Nephrol Dial Transplant 2012; 27 (suppl 3): iii146-iii151
74. Nguyen S, McCulloch C, Brakeman P et al. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics 2008; 121: 37-45
75. United States Renal Data System 2007 Annual Report. United States Renal Data System. Available at http://www.kidney.niddk.nih.gov (13 February 2013, date last accessed)
76. Ferris M, Hogan SL, Chin H et al. Obesity, Albuminuria, and Urinalysis Findings in US Young Adults from the Add HealthWave 3 Study. Clin J Am Soc Nephrol 2007; 2: 1207-1214
77. Pavkov ME, Bennett PH, Knowler WC et al. Effect of youthonset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle- aged Pima Indians. JAMA 2006; 296: 421-426
78. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576
79. Siebenhofer A, Jeitler K, Berghold A et al. Long-term effects of weight-reducing diets in hypertensive patients. Cochrane Database Syst Rev 2011; 9: CD008274
80. Epstein LH, Myers MD, Raynor HA et al. Treatment of pediatric obesity. Pediatrics 1998; 101: 554-570
81. Pacifico L, Anania C, Martino F et al. Management of metabolic syndrome in children and adolescents. Nutr Metab Cardiovasc Dis 2011; 21: 455-466
82. Litwin M, Niemirska A, Śladowska-Kozlowska J et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol 2010; 25: 2489-2499
83. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and endstag erenal disease in men. N Engl J Med 1996; 334: 13-18
84. Staples AO, Greenbaum LA, Smith JM et al. Association between clinical risk factors and progression of chronic kidney disease in children. Clin J Am Soc Nephrol 2010; 5: 2172-2179
85. Locatelli F, Marcelli D, Comelli M et al. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. Nephrol Dial Transplant 1996; 11: 461-467
86. Mitsnefes M, Ho P-L, McEnery PT. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 2003; 14: 2618-2622
87. ESCAPE Trial GroupWühl E, Trivelli A, Picca S et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639-1650
88. Hamilton RA, Kane MP, Demers J. Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: a metaanalysis. Pharmacotherapy 2003; 23: 909-915
89. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin- receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860
90. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensinconverting- enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462
91. McCrindle BW, Urbina EM, Dennison BA et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948-1967
92. O'Gorman CSM, O'Neill MB, Conwell LS. Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits. Vasc Health Risk Manage 2011; 7: 1-14
93. Braamskamp MJAM, Wijburg FA, Wiegman A. Drug therapy of hypercholesterolaemia in children and adolescents. Drugs 2012; 72: 759-772
94. Wiegand S, l'Allemand D, Hübel H et al. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective,placebo-controlled, randomized study. Eur J Endocrinol 2010; 163: 585-592
95. Viner RM, Hsia Y, Tomsic T et al. Efficacy and safety of antiobesity drugs in children and adolescents: systematic review and meta-analysis. Obes Rev 2010; 11: 593-602
96. Catoira N, Nagel M, Di Girolamo G et al. Pharmacological treatment of obesity in children and adolescents: current status and perspectives. Expert Opin Pharmacother 2010; 11: 2973-2983
97. Keidar A, Hecht L, Weiss R. Bariatric surgery in obese adolescents. Curr Opin Clin Nutr Metab Care 2011; 14: 286-290